Windtree Therapeutics Faces Delisting Concerns
Ticker: WINTW · Form: 8-K · Filed: Jun 20, 2025 · CIK: 946486
| Field | Detail |
|---|---|
| Company | Windtree Therapeutics Inc /De/ (WINTW) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
Windtree Therapeutics might get delisted - stock exchange rules are a problem.
AI Summary
Windtree Therapeutics, Inc. filed an 8-K on June 20, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event reported on June 18, 2025. The company, formerly known as Discovery Laboratories Inc., is incorporated in Delaware and headquartered in Warrington, Pennsylvania.
Why It Matters
This filing indicates potential issues with Windtree Therapeutics' compliance with stock exchange listing requirements, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.
Key Numbers
- 001-39290 — SEC File Number (Identifies the company's filing with the SEC.)
- 94-3171943 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Windtree Therapeutics, Inc. (company) — Registrant
- Discovery Laboratories Inc. (company) — Former company name
- June 18, 2025 (date) — Earliest event reported
- June 20, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Warrington, Pennsylvania (location) — Business address
FAQ
What specific listing rule or standard has Windtree Therapeutics failed to satisfy?
The filing does not specify the exact rule or standard that was not met, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the earliest date associated with the event reported in this 8-K?
The earliest event reported is dated June 18, 2025.
When was this 8-K form filed with the SEC?
This 8-K form was filed on June 20, 2025.
What was Windtree Therapeutics' former company name?
Windtree Therapeutics, Inc. was formerly known as Discovery Laboratories Inc. /DE/.
Where is Windtree Therapeutics, Inc. headquartered?
The company's business address is listed as 2600 Kelly Road, Suite 100, Warrington, Pennsylvania 18976.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding WINDTREE THERAPEUTICS INC /DE/ (WINTW).